Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia

Leukemia & Lymphoma
Mark DrummondTessa Holyoake

Abstract

Chronic myeloid leukemia (CML) is associated increased stem cell turnover. We have previously shown that short telomeres in chronic phase (CP) predict for early progression to blast phase (BP). Poor prognostic score patients may therefore exhibit increased telomere loss at diagnosis and/or a greater than normal rate of loss during the disease course. We prospectively studied newly diagnosed CML patients for degree of telomere loss; measured telomere length in CML patients at all stages of disease; and performed follow-up sampling according to cytogenetic response to imatinib mesylate. Using flow-FISH, telomere length in peripheral blood leucocytes (PBL) from 32 consecutive newly diagnosed patients was measured (with ex-vivo expanded T-cells as an internal BCR-ABL negative control), in addition to 65 samples from all CML stages and 7 paired CP/BP samples. Fifty-five normal individuals served as a control population. Patients who attained either a complete cytogenetic response (CCR, 0% Ph+, n = 10) or no CR (100% Ph+, n = 11) underwent follow-up measurement. All statistical tests were two sided. Telomeres in accelerated phase (AP) and BP patients were significantly shorter than in CP, and mean telomere shortening was significantl...Continue Reading

References

May 31, 1990·Nature·C B HarleyC W Greider
Feb 3, 2000·Free Radical Biology & Medicine·T von ZglinickiN Sitte
Jun 2, 2000·The Journal of Biological Chemistry·M SattlerJ D Griffin
Mar 27, 2001·Blood·E DeutschJ Bourhis
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers

❮ Previous
Next ❯

Citations

Jun 6, 2006·Breast Cancer Research and Treatment·Colleen A FordyceJeffrey K Griffith
Oct 27, 2005·Onkologie·Tim H Brümmendorf
May 19, 2007·Stem Cells·Mark W DrummondTim H Brummendorf
Jan 12, 2012·British Journal of Haematology·Ceri H JonesDuncan M Baird
Aug 23, 2005·Cancer Chemotherapy and Biological Response Modifiers·Peter H Wiernik
May 8, 2009·Biochimica Et Biophysica Acta·Ulrika Svenson, Göran Roos
May 25, 2007·Nature Reviews. Cancer·Junia V Melo, David J Barnes
Nov 25, 2004·Hematology·Stephen O'BrienPeter Valent
Jan 6, 2017·Current Protocols in Cytometry·Theodoros Kelesidis, Ingrid Schmid
May 24, 2016·Current Opinion in Hematology·Claudia Bruedigam, Steven W Lane
Jul 31, 2016·Journal of Hematology & Oncology·Giovanni CaocciGiorgio La Nasa
Oct 3, 2018·Journal of the National Cancer Institute·Lisa GallicchioNaoko I Simonds
Mar 17, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Balal BrazvanHojjatollah Nozad Charoudeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.